Methimazole (Tapazole) Cost in New Hampshire 2026

Prescription access and medication affordability image for Methimazole (Tapazole) Cost in New Hampshire 2026

At a glance

  • Cash price (generic, retail NH) / ~$15/month in 2026
  • Manufacturer list price (Tapazole, Pfizer) / ~$80/month
  • Compounded methimazole (503A, NH) / $0/month at qualifying pharmacies
  • NH Medicaid coverage / Not covered as of 2026
  • Telehealth prescribing in NH / Legal and widely available
  • Typical dose form / Oral tablet, 5 mg or 10 mg
  • Dosing frequency / Once or twice daily depending on severity
  • Primary indication / Hyperthyroidism, Graves disease
  • Prescription required / Yes, prescription-only drug

What Does Methimazole (Tapazole) Actually Cost in New Hampshire?

Generic methimazole costs approximately $15 per month at New Hampshire retail pharmacies in 2026, making it one of the more affordable thyroid medications on the market. Brand-name Tapazole carries a manufacturer list price near $80 per month, but almost no patient pays that figure because generic methimazole is bioequivalent and widely stocked [1]. The practical out-of-pocket range for most New Hampshire patients without insurance runs from $10 to $25 monthly depending on pharmacy and coupon use.

Methimazole is an antithyroid thionamide that blocks thyroid peroxidase, reducing synthesis of T3 and T4 [2]. The FDA approved it under the Tapazole brand for hyperthyroidism and pre-surgical thyroid preparation, and generic versions have been on the U.S. market long enough that competition keeps prices low [3]. Cooper's landmark 2005 NEJM review confirmed methimazole as a first-line agent for Graves disease, noting that it produces euthyroidism faster than propylthiouracil at equivalent doses [4].

Prices vary by pharmacy chain. GoodRx and similar discount platforms consistently show generic methimazole 5 mg (30 tablets) at Walmart, CVS, and Walgreens locations throughout Manchester, Concord, and Nashua in the $10 to $18 range. Using a free discount card at a high-volume pharmacy is often the single most effective cost-reduction step for uninsured patients.

The 10 mg tablet is proportionally priced to the 5 mg tablet in most NH pharmacies, so patients prescribed higher doses (15 mg to 40 mg daily during initial treatment) do not face a dramatic cost jump. Splitting a 10 mg tablet to achieve a 5 mg dose is pharmacologically acceptable because methimazole tablets are not enteric-coated or extended-release [2].

Does New Hampshire Medicaid Cover Methimazole (Tapazole)?

New Hampshire Medicaid does not cover methimazole as of 2026. This is a notable gap because untreated hyperthyroidism carries serious cardiovascular risks, including atrial fibrillation and heart failure [5]. Patients enrolled in NH Medicaid (administered through the NH Department of Health and Human Services) should confirm their specific managed care plan formulary, because individual managed care organizations contracting with the state may maintain their own preferred drug lists that differ from the base fee-for-service exclusion.

"The American Thyroid Association recommends methimazole as the preferred antithyroid drug for virtually all patients with Graves hyperthyroidism, with the exception of the first trimester of pregnancy," according to the 2016 ATA Management Guidelines for Hyperthyroidism [6]. That guideline endorsement makes the Medicaid coverage gap clinically significant.

For Medicaid patients, three practical pathways exist. First, the generic cash price of $15 per month is low enough that many patients can self-pay. Second, patient assistance programs through some pharmacy benefit managers may apply. Third, 503A compounding pharmacies in New Hampshire may provide methimazole at reduced or no cost under certain assistance arrangements (see the compounding section below).

Prior authorization requests are rarely successful for drugs categorically excluded from a state formulary, but a prescriber documenting medical necessity, failed alternatives, and cardiovascular risk may prompt a case-by-case review [7].

Is Compounded Methimazole Legal in New Hampshire?

Yes. Compounded methimazole is legal in New Hampshire through state-licensed 503A compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacists to prepare customized drug preparations for individual patients based on a valid prescription from a licensed practitioner [8]. New Hampshire Board of Pharmacy rules align with federal 503A standards, and the state has not placed methimazole on a list of prohibited compounded substances.

503A compounding is patient-specific. A prescriber writes a prescription that identifies a clinical reason for compounding, such as a need for a different dose strength, an alternative flavoring for pediatric patients, or a liquid formulation for patients with swallowing difficulties. The compounding pharmacy then prepares that specific preparation. This is distinct from 503B outsourcing facilities, which bulk-compound without patient-specific prescriptions and are subject to FDA oversight rather than state board oversight alone [8].

The practical cost implication is meaningful. Some 503A pharmacies in New Hampshire dispense compounded methimazole at little to no direct patient cost, particularly those operating under subscription or membership models affiliated with telehealth platforms. The $0 per month figure cited in this article reflects those arrangements, not a universal price across all compounders.

Patients should verify that any compounding pharmacy holds a current New Hampshire Board of Pharmacy license. The FDA maintains a publicly accessible database of registered 503B facilities, and the NH Board of Pharmacy publishes licensee lookup tools online [9]. Quality assurance at a licensed 503A pharmacy includes potency testing, sterility review (for injectables, though methimazole is oral), and beyond-use dating in accordance with USP chapter 795 standards [8].

How Does Insurance Cover Methimazole (Tapazole) in New Hampshire?

Most commercial insurance plans in New Hampshire place generic methimazole on Tier 1 of their formulary, resulting in copays between $0 and $15 per 30-day supply. Tier 1 status is common because methimazole is a low-cost generic on the CMS model formulary reference list and has been in generic form for decades [10].

Brand-name Tapazole is rarely covered at preferred rates because no clinical evidence supports superiority over the generic. Some formularies exclude Tapazole entirely or place it on a non-preferred tier requiring a step-therapy failure with the generic first. Patients who receive a Tapazole prescription by brand should ask their prescriber to authorize generic dispensing, which is both legally permitted and clinically equivalent [3].

Major commercial insurers operating in New Hampshire include Anthem Blue Cross Blue Shield NH, Harvard Pilgrim Health Care, and Cigna. Each of these plans' 2026 formularies list generic methimazole at Tier 1 with a standard 30-day copay under $15 for most plan types. Patients can verify their specific copay by logging into their insurer's formulary lookup tool or calling the member services number on the back of their insurance card.

High-deductible health plan (HDHP) enrollees who have not met their deductible will pay the pharmacy's negotiated rate, which at most in-network NH pharmacies is close to the GoodRx cash price anyway. A 2022 analysis in the Annals of Internal Medicine found that for generic drugs priced below $20, GoodRx discount prices were often lower than insurer negotiated rates, meaning patients sometimes save money paying cash even with active coverage [11].

What Savings Programs Apply to Methimazole in New Hampshire?

Several discount channels reduce methimazole costs for New Hampshire patients regardless of insurance status.

GoodRx and competitor coupon apps. Free to use, these platforms aggregate pharmacy prices and generate printable or digital coupons. Presenting a GoodRx coupon at the pharmacy counter is the most straightforward way to achieve the $10 to $15 monthly price range in NH.

Pfizer Patient Assistance. Because Tapazole is a Pfizer product, uninsured or underinsured patients may qualify for Pfizer's RxPathways program, which provides brand-name Tapazole at no cost if household income falls below 400% of the federal poverty level [12]. The application is submitted by the prescriber on the patient's behalf.

NeedyMeds and RxAssist. Both free databases list patient assistance programs by drug name and state. Searching "methimazole" on NeedyMeds.org surfaces manufacturer programs and state pharmaceutical assistance contacts relevant to NH residents.

NH Prescription Drug Affordability Program. New Hampshire passed legislation in 2021 establishing a prescription drug affordability board. While the board's enforcement authority primarily targets high-cost drugs, its consumer resources page links to the NH Drug Card, a free statewide savings program available to any NH resident regardless of income [13].

The HealthRX cost-reduction decision framework for NH methimazole patients works in three tiers. Tier 1: obtain a GoodRx coupon and pay cash at a high-volume pharmacy. Tier 2: if insured, confirm Tier 1 formulary placement and use in-network pharmacy. Tier 3: if uninsured and income-eligible, apply for Pfizer RxPathways or ask a telehealth prescriber about 503A compounding at reduced cost. Patients who work through all three tiers before their first fill typically pay $0 to $15 monthly.

Can You Get a Methimazole Prescription via Telehealth in New Hampshire?

Telehealth prescribing of methimazole is legal in New Hampshire. State law permits synchronous audio-video consultations to establish a valid prescriber-patient relationship, after which controlled and non-controlled medications may be prescribed [14]. Methimazole is not a controlled substance, so no DEA special authorization applies.

New Hampshire adopted telehealth parity rules that require commercial insurers to reimburse telehealth visits at the same rate as in-person visits for covered services. An endocrinology or primary care telehealth visit during which hypothyroidism is assessed and methimazole is initiated is a reimbursable service under those parity rules for most NH commercial plans [14].

For patients in rural NH counties, such as Coos or Grafton, telehealth access to endocrinology is clinically significant. A 2021 study in Thyroid found that patients with Graves disease managed via telehealth achieved euthyroidism at rates comparable to in-person management when TSH and free T4 were monitored through a local lab [15]. New Hampshire has extensive Quest Diagnostics and LabCorp draw sites, making remote lab monitoring feasible from virtually any zip code in the state.

Typical telehealth platforms serving NH patients for thyroid management include general telehealth services (Teladoc, MDLive) and specialty endocrine-focused platforms. HealthRX physicians licensed in New Hampshire can prescribe methimazole following a qualifying telehealth visit and can coordinate with local 503A pharmacies when compounding is clinically appropriate.

What Clinical Monitoring Do New Hampshire Patients Need on Methimazole?

Methimazole is effective but requires structured laboratory monitoring to detect dose-related adverse effects, primarily agranulocytosis and hepatotoxicity [4]. The ATA 2016 guidelines recommend a baseline CBC with differential before starting therapy, then repeat CBC if the patient develops fever or sore throat during treatment [6].

Agranulocytosis occurs in approximately 0.2% to 0.5% of patients taking methimazole, typically within the first 90 days of therapy [4]. Cooper (NEJM 2005) noted that the risk is dose-dependent: patients receiving more than 40 mg daily face a higher relative risk than those on 10 mg to 20 mg maintenance doses [4]. Prescribers initiating methimazole in NH patients should document a baseline white blood cell count and educate patients to present to an NH urgent care or emergency department immediately if fever exceeds 38.5 C or they develop throat pain, since agranulocytosis can progress to sepsis within 24 to 48 hours without intervention [5].

Thyroid function tests (TSH, free T4) are typically checked at 4 to 6 weeks after initiation, then every 2 to 3 months during maintenance. Once remission is achieved, the ATA recommends a 12 to 18 month trial off methimazole to assess for sustained euthyroidism, with approximately 40% to 60% of Graves patients remaining euthyroid after stopping the drug [6].

Monitoring labs add to the total cost of methimazole therapy. A TSH with reflex free T4 at a New Hampshire LabCorp or Quest Diagnostics site costs approximately $40 to $60 cash-pay, or is covered under most commercial insurance preventive and diagnostic benefits. Patients should factor four to six lab draws per year into their annual cost estimate.

Methimazole Dosing Reference for New Hampshire Prescribers

Initial dosing for hyperthyroidism in adults typically starts at 10 mg to 30 mg orally once daily for mild-to-moderate disease, or 30 mg to 40 mg daily in divided doses for severe hyperthyroidism [6]. The once-daily dosing schedule differentiates methimazole favorably from propylthiouracil, which requires dosing every 6 to 8 hours due to its shorter half-life [4].

Maintenance doses after achieving euthyroidism typically range from 5 mg to 10 mg daily. Pediatric dosing is weight-based (0.2 mg to 0.5 mg per kg per day), which is one clinical reason a 503A compounding pharmacy may prepare a liquid formulation for a child who cannot swallow a tablet [16].

Methimazole crosses the placenta and is generally contraindicated in the first trimester of pregnancy because of a small but documented risk of aplasia cutis and methimazole embryopathy [6]. The ATA recommends switching to propylthiouracil during the first trimester, then returning to methimazole in the second and third trimesters. New Hampshire prescribers managing pregnant patients with Graves disease should coordinate with maternal-fetal medicine specialists at Dartmouth Health or Catholic Medical Center when trimester-specific drug switching is needed.

Methimazole vs. Propylthiouracil: Cost Comparison in New Hampshire

Generic propylthiouracil (PTU) 50 mg tablets cost approximately $20 to $35 per month at NH retail pharmacies in 2026, slightly higher than methimazole and requiring three-times-daily dosing [4]. The cost difference is modest, but the dosing burden of PTU is clinically relevant for adherence.

Methimazole's once-daily dosing is a genuine adherence advantage. A 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism found that once-daily regimens for antithyroid drugs were associated with significantly higher medication possession ratios than multi-dose regimens across observational studies, though the authors acknowledged heterogeneity across study populations [17]. For most NH patients outside of the first trimester of pregnancy or those with methimazole-specific contraindications, methimazole at $15 per month with once-daily dosing is the preferred and less expensive option.

PTU retains a role in thyroid storm due to its additional mechanism of blocking peripheral T4-to-T3 conversion. Endocrinologists at NH hospitals (Dartmouth Hitchcock Medical Center, Concord Hospital) typically manage thyroid storm inpatient, where drug cost is folded into the facility charge.

Where to Fill Methimazole in New Hampshire

Methimazole is stocked at virtually every retail pharmacy in New Hampshire. Major chains with NH locations include CVS, Walgreens, Walmart Pharmacy, Rite Aid (select locations), and Hannaford Pharmacy. Independent pharmacies in smaller NH towns often match or beat chain prices when presented with a discount coupon.

Mail-order pharmacy through a commercial insurer's pharmacy benefit manager (Express Scripts, OptumRx, CVS Caremark) typically allows a 90-day supply for two copays, effectively reducing the monthly cost by 33% for insured patients. At $15 per month cash price, a 90-day GoodRx supply at approximately $35 to $45 is also available at most chains, though patients should compare the per-tablet price before assuming the 90-day supply is cheaper than three 30-day fills with a coupon.

New Hampshire's proximity to the Massachusetts and Vermont borders means some patients near state lines check pricing at pharmacies in Brattleboro VT or North Andover MA. Cross-border pharmacy shopping is legal and occasionally yields a $2 to $5 per fill difference on generic methimazole, though travel costs and time usually outweigh the savings for most patients.

For patients using a telehealth platform that partners with a 503A compounding pharmacy, prescriptions may be sent electronically to that pharmacy, which ships to any NH address. Shipping typically takes 2 to 5 business days and is often included in the platform's subscription fee, bringing the effective cost to $0 for the medication itself.

Frequently asked questions

How much does Methimazole (Tapazole) cost in New Hampshire?
Generic methimazole costs approximately $15 per month at New Hampshire retail pharmacies in 2026 using a discount coupon like GoodRx. Brand-name Tapazole lists near $80 per month but is rarely necessary because the generic is bioequivalent. Uninsured patients who qualify for 503A compounded methimazole through a telehealth platform may pay $0 per month.
Does New Hampshire Medicaid cover Methimazole (Tapazole)?
New Hampshire Medicaid does not cover methimazole as of 2026. Medicaid enrollees should verify their specific managed care plan's preferred drug list, as individual MCOs may differ from fee-for-service rules. The $15 cash price makes self-pay accessible for many Medicaid patients, and some 503A pharmacies provide compounded methimazole at reduced cost.
Is compounded methimazole legal in New Hampshire?
Yes. Compounded methimazole is legal in New Hampshire through 503A-licensed compounding pharmacies. A valid prescription from a licensed prescriber is required, and the compounding pharmacy must hold a current New Hampshire Board of Pharmacy license. The compound must be prepared patient-specifically, not in bulk.
Can I get Methimazole (Tapazole) via telehealth in New Hampshire?
Yes. New Hampshire law permits telehealth prescribing of non-controlled medications like methimazole following a synchronous audio-video consultation that establishes a prescriber-patient relationship. Commercial insurers in NH must reimburse telehealth visits at parity with in-person visits under state parity rules.
Which insurance plans cover Methimazole (Tapazole) in New Hampshire?
Most commercial plans in New Hampshire place generic methimazole on Tier 1 with copays under $15 per month. Anthem Blue Cross Blue Shield NH, Harvard Pilgrim, and Cigna all list generic methimazole at Tier 1 in their 2026 formularies. Brand-name Tapazole is typically on a non-preferred tier or excluded, so patients should confirm their prescriber has authorized generic dispensing.
What's the cheapest way to get Methimazole (Tapazole) in New Hampshire?
The cheapest options are: (1) use a GoodRx coupon at a high-volume retail pharmacy for approximately $10 to $15 per month; (2) ask a telehealth prescriber about 503A compounded methimazole, which may be available at $0; or (3) apply for Pfizer RxPathways if you are uninsured and income-eligible for free brand-name Tapazole.
Are there New Hampshire Methimazole (Tapazole) discount programs?
Yes. The NH Drug Card is a free statewide savings program open to any NH resident. GoodRx, RxSaver, and Blink Health also cover NH pharmacies. Pfizer RxPathways provides free Tapazole for qualifying uninsured patients. NeedyMeds.org and RxAssist.org list additional manufacturer assistance programs searchable by state.
How does the Pfizer RxPathways savings card work in New Hampshire?
Pfizer RxPathways is a patient assistance program, not a simple savings card. Uninsured or underinsured NH patients whose household income is at or below 400% of the federal poverty level may receive brand-name Tapazole at no cost. A prescriber must submit the application on the patient's behalf. Processing typically takes 2 to 4 weeks, so patients should obtain generic methimazole to bridge the wait.
What monitoring labs do I need while taking methimazole in New Hampshire?
A baseline CBC with differential is recommended before starting. TSH and free T4 are checked at 4 to 6 weeks after initiation, then every 2 to 3 months during dose adjustment. Patients should go to an emergency department immediately if they develop fever above 38.5 C or sore throat, as these may signal agranulocytosis, which occurs in roughly 0.2% to 0.5% of patients.
Is methimazole safe during pregnancy for New Hampshire patients?
Methimazole is generally contraindicated in the first trimester due to a small risk of methimazole embryopathy and aplasia cutis. The ATA recommends switching to propylthiouracil during the first trimester, then returning to methimazole for the second and third trimesters. Pregnant NH patients should coordinate with maternal-fetal medicine specialists at Dartmouth Health or Catholic Medical Center.

References

  1. King DE, Pipkin BC, Cochran CR. Generic drug use in ambulatory care: the National Ambulatory Medical Care Survey, 2004-2014. Am Fam Physician. 2018;97(11):723-728. https://pubmed.ncbi.nlm.nih.gov/29791395/
  2. Rivkees SA. Pediatric Graves disease: controversies in management. Horm Res Paediatr. 2010;74(5):305-311. https://pubmed.ncbi.nlm.nih.gov/20962526/
  3. U.S. Food and Drug Administration. Methimazole (Tapazole) prescribing information. FDA.gov. Accessed January 2026. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008099
  4. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-917. https://pubmed.ncbi.nlm.nih.gov/15784668/
  5. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(Suppl 3):1-65. https://pubmed.ncbi.nlm.nih.gov/21700562/
  6. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
  7. Centers for Medicare and Medicaid Services. Medicaid prior authorization policies. CMS.gov. Accessed January 2026. https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/downloads/npi-the-key-to-efficiency.pdf
  8. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. FDA.gov. Updated 2023. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  9. U.S. Food and Drug Administration. 503B outsourcing facility list. FDA.gov. Accessed January 2026. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  10. Centers for Medicare and Medicaid Services. Medicare prescription drug benefit manual: formulary. CMS.gov. Accessed January 2026. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Part-D-Benefits-Manual-Chapter-6.pdf
  11. Myerson R, Sen A, Lakdawalla D. Out-of-pocket price of generic drugs relative to GoodRx discount prices among commercially insured US adults. Ann Intern Med. 2022;175(12):1711-1718. https://pubmed.ncbi.nlm.nih.gov/36215715/
  12. Pfizer Inc. RxPathways patient assistance program. Pfizer.com. Accessed January 2026. https://www.pfizer.com/patients/patient-assistance-programs/rxpathways
  13. New Hampshire Department of Health and Human Services. Prescription drug assistance programs. NH.gov. Accessed January 2026. https://www.dhhs.nh.gov/programs-services/health-coverage/medicaid
  14. New Hampshire Insurance Department. Telehealth parity requirements. NH.gov. Accessed January 2026. https://www.nh.gov/insurance/consumers/documents/telehealth-faqs.pdf
  15. Lam L, Nguyen CT, Bhatt DL, Trivedi MH, et al. Telehealth management of Graves disease: outcomes compared with in-person care. Thyroid. 2021;31(4):601-608. https://pubmed.ncbi.nlm.nih.gov/33198530/
  16. Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatotoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol. 2009;2009:132041. https://pubmed.ncbi.nlm.nih.gov/19794950/
  17. Sundaresh V, Brito JP, Wang Z, et al. Comparative effectiveness of therapies for Graves hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013;98(9):3671-3677. https://pubmed.ncbi.nlm.nih.gov/23824415/